Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be participating in 'Emkay Confluence - Ideas for a $5trn Economy' Virtual Investor Conference on Wednesday, August 10, 2022. We enclose the names of the Investors/ Analysts participating in the same. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/ Company. We also enclose the presentation to be used during the e-conference. This is for your information and record.
08-08-2022
Bigul

Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that audio recording of investors conference call for Un-audited financial results for the quarter ended June 30, 2022 held on Friday, August 5, 2022, has been uploaded on the Company''s website. The link to access the audio call recording is: https://jubilantingrevia.com/Uploads/files/6q4consfileJubilantIngreviaLimited-Q1FY23ResultConcallAudio.mp3 This is for your information and records.
06-08-2022
Bigul

Jubilant Ingrevia Ltd - 543271 - Intimation Of Record Date For The Purpose Of Declaration Of Final Dividend For The Financial Year 2021-22

 In continuation to the Company's letter dated May 17, 2022, we wish to inform you that Board of Directors at its meeting held today, has fixed record date for the purpose of determining the eligibility of the shareholders for the payment of Final Dividend of Rs. 2.50 (Two Rupees and Fifty paisa) per equity share of Re. 1 each for the Financial Year ended March 31, 2022 as per details given below: Record Date - Wednesday, August 24, 2022 The Final dividend, if approved by the shareholders at the ensuing AGM, will be paid/ dispatched on or before October 25, 2022. This is for your information and record.
05-08-2022
Bigul

Q1FY23 Quarterly Result Announced for Jubilant Ingrevia Ltd.

 Specialty Chemicals firm Jubilant Ingrevia Announced Q1FY23 Result : Overall Revenue grew by 2% on YoY basis, mainly due to higher sales performance by Speciality Chemical Business. Speciality Chemicals revenue grew by 26% YoY driven by volume growth across product segments Nutrition and Health Solutions business performance was impacted mainly due to spreading of Bird & Swine Flu in EU & US region resulting into lower demand. This is a short-term challenge in the segment, and business continues to maintain its market share and leadership position. Chemical Intermediates volume have grown while revenue is impacted mainly due to lower prices of key RM i.e. Acetic Acid. EBITDA at Rs 151 Crore is lower by 47%, mainly due to Chemical Intermediate EBITDA normalization. Nutrition Margins were impacted due to lower sale, while Speciality Margins were impacted due to higher input costs which were passed on partially. PAT declined by 53% YoY driven by lower EBITDA, as explained above. ROCE for the quarter stood at 20.8% as against 27.8% in FY22 on TTM Basis ROE during the quarter stood at 15.7% as against 21.9% in ’FY22 on TTM basis Commenting on the Company’s performance, Mr. Shyam S Bhartia, Chairman and Mr. Hari S Bhartia, CoChairman, Jubilant Ingrevia Limited said: “We are glad to announce steady operational and financial performance in Q1’FY23, in the backdrop of inflationary headwinds leading to higher raw material and energy costs during the quarter. In our Specialty Chemicals Business revenue grew 26% YoY, on account of strong demand across all our product segments. We witnessed significant increase in input costs Including energy costs, which was passed on partially during the quarter, impacting segment’s EBITDA margin. In our Nutrition & Health Solution Business, Niacinamide sales volume were significantly impacted due to spread of Avian and Swine Flu in EU and US regions leading to lower segment revenue and EBIDTA, however the price realization was better during the quarter. This is a short-term challenge in the segment, and business continues to maintain its market share and leadership position. Our Chemical Intermediates Business, continue to witness strong demand resulting into volume growth. Business is maintaining the leadership position of Acetic Anhydride in Domestic market and also Improving our market share in Europe. On YoY basis segment has witnessed normalization of market situation and lower Acetic Acid prices, which is also reflecting into both Revenue and EBITDA. We are fully committed towards our growth aspirations and we are excited to realise the emerging opportunities going forward in all our business segments. We are fully confident of moving ahead with our well defined growth capex plan, which is supported by our internal accruals. Our aim is to achieve sustainable profitable growth in medium term and structurally we are poised towards moving on to the next tier of performance in our growth journey and margins”. Result PDF
05-08-2022
Bigul

Jubilant Ingrevia Ltd - 543271 - Intimation Of Date Of Annual General Meeting And Final Dividend Payout Date

 We wish to inform you that the Board of Directors of the Company has, at its meeting held today i.e. August 5, 2022, fixed the date of Annual General Meeting (the 'AGM') of the Company as Monday, September 26, 2022 through Other Audio Visual Means. Accordingly, in furtherance to our letter dated May 17, 2022, the final dividend, if approved by the shareholders at the ensuing AGM, will be paid/ dispatched on or before October 25, 2022. We request you to take the same on record.
05-08-2022
Bigul

Jubilant Ingrevia Ltd - 543271 - Board Meeting Outcome for Unaudited Financial Results

 In terms of Regulations 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2022 were approved by the Board of Directors of the Company at its meeting held today at 11:15 a.m. and concluded at 01:15 p.m. Pursuant to the applicable provisions of the Listing Regulations, we enclose the following: 1. The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2022; 2. Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter; and; 3. Copies of the Press Release and Presentation. We request you to take the same on records.
05-08-2022
Bigul

Jubilant Ingrevia Ltd - 543271 - Grant Of Options Under Jubilant Ingrevia Employees Stock Option Plan 2021

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Nomination, Remuneration and Compensation Committee of the Company has, at its meeting held on Monday, August 1, 2022, granted stock options to the eligible employees as mentioned in the Intimation Letter.
02-08-2022
Bigul

Jubilant Ingrevia Ltd - 543271 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company is organising a Conference Call on Friday, August 5, 2022 after submission of the financial results for the quarter ended June 30, 2022 to the Stock Exchanges. Details of the Conference Call are attached.
28-07-2022
Bigul

Jubilant Ingrevia Ltd - 543271 - Board Meeting Intimation for August 5, 2022

 Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2022 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2022.
28-07-2022
Bigul

Jubilant Ingrevia Ltd - 543271 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a share certificate has been reported to be lost as stated in the enclosed Intimation Letter. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record.
26-07-2022
Next Page
Close

Let's Open Free Demat Account